Ignite Creation Date:
2024-05-06 @ 2:23 AM
Last Modification Date:
2024-10-26 @ 11:17 AM
Study NCT ID:
NCT02035657
Status:
COMPLETED
Last Update Posted:
2018-06-13
First Post:
2014-01-10
Brief Title:
A Proof-of-Concept Trial of GLA-SE in Patients With Merkel Cell Carcinoma
Sponsor:
Immune Design a subsidiary of Merck Co Inc Rahway New Jersey USA
Organization:
Immune Design a subsidiary of Merck Co Inc Rahway New Jersey USA
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-01
Start Date Type:
ACTUAL
Primary Completion Date:
2018-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-03
Completion Date Type:
ACTUAL
First Submit Date:
2014-01-10
First Submit QC Date:
January 13 2014
Study First Post Date:
2014-01-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-06-11
Last Update Post Date:
2018-06-13
Last Update Post Date Type:
ACTUAL